Effectiveness of the Standard WHO Recommended Retreatment Regimen (Category II) for Tuberculosis in Kampala, Uganda A Prospective Cohort Study 英文参考文献.docVIP

下载本文档

4
0
约5.87万字
约 11页
2017-05-11 发布于上海
举报
版权申诉

Effectiveness of the Standard WHO Recommended Retreatment Regimen (Category II) for Tuberculosis in Kampala, Uganda A Prospective Cohort Study 英文参考文献.doc

1、本文档共11页，可阅读全部内容。
2、原创力文档（book118）网站文档一经付费（服务费），不意味着购买了该文档的版权，仅供个人/单位学习、研究之用，不得用于商业用途，未经授权，严禁复制、发行、汇编、翻译或者网络传播等，侵权必究。
3、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己接受本站规则且自行承担风险，本站不退款、不进行额外附加服务；查看《如何避免下载的几个坑》。如果您已付费下载过本站文档，您可以点击这里二次下载。
4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等，请点击“版权申诉”（推荐），也可以打举报电话：400-050-0827(电话支持时间：9:00-18:30)。
5、该文档为VIP文档，如果想要下载，成为VIP会员后，下载免费。
6、成为VIP后，下载本文档将扣除1次下载权益。下载后，不支持退款、换文档。如有疑问请联系我们。
7、成为VIP后，您将拥有八大权益，权益包括：VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
8、VIP文档为合作方或网友上传，每下载1次，网站将根据用户上传文档的质量评分、类型等，对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档

Effectiveness of the Standard WHO Recommended Retreatment Regimen (Category II) for Tuberculosis in Kampala, Uganda A Prospective Cohort Study 英文参考文献

EffectivenessoftheStandardWHORecommended RetreatmentRegimen(CategoryII)forTuberculosisin Kampala,Uganda:AProspectiveCohortStudy EdwardC.Jones-Lo′pez1,2,3.*,IreneAyakaka2.,JonathanLevin4,5,NancyReilly3,FrancisMumbowa6, ScottDryden-Peterson7,GraceNyakoojo2,KevinFennelly2,8,BethTemple4¤,SusanNakubulwa4, MosesL.Joloba6,AlphonseOkwera2,9,KathleenD.Eisenach10,RuthMcNerney11,AlisonM.Elliott11,12, JerroldJ.Ellner1,2,PeterG.Smith13,RoyD.Mugerwa2,12 1SectionofInfectiousDiseases, DepartmentofMedicine,BostonMedicalCenter,BostonUniversityMedicalSchool,Boston, Massachusetts, UnitedStatesofAmerica, 2MakerereUniversity–UniversityofMedicineandDentistryofNewJersey(UMDNJ)ResearchCollaboration,Kampala,Uganda,3DepartmentofMedicine,NewJersey MedicalSchool–UMDNJ,Newark,NewJersey,UnitedStatesofAmerica, 4MedicalResearchCouncil–UgandaVirusResearchInstitute,UgandaResearchUnitonAIDS, Entebbe,Uganda,5SchoolofPublicHealth,UniversityoftheWitwatersrand,Johannesburg,SouthAfrica,6DepartmentofMicrobiology,MakerereUniversityCollegeof Health Sciences, Kampala, Uganda, 7Division of Infectious Diseases, Brigham Women’s Hospital, Harvard Medical School, Boston, Massachusetts, United States of America,8SoutheasternNationalTuberculosisCenter,DivisionofMycobacteriology,DepartmentofMedicine,UniversityofFlorida,Gainesville,Florida,UnitedStatesof America, 9Mulago Hospital Tuberculosis Clinic, Mulago Hospital, Kampala, Uganda, 10Departments of Pathology and, Microbiology and Immunology, University of ArkansasforMedicalSciences,LittleRock,Arkansas,UnitedStatesofAmerica,11DepartmentsofInfectiousandTropicalDiseases,LondonSchoolofHygieneTropical Medicine, London, United Kingdom, 12Departmentof Medicine, Makerere University College of Health Sciences, Kampala, Uganda, 13Epidemiology and Population Health,LondonSchoolofHygieneTropicalMedicine,London,UnitedKingdom Abstract Background: Each year, 10%–20% of patients with tuberculosis (TB) in low- and middle-income countries present with previously treated